CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...